Proposal to Modify Existing or Establish New Requirements for the Informed Consent of Living Donors (Resolution 18) Living Donor Committee Mary Amanda.

Slides:



Advertisements
Similar presentations
OPTN OPO Committee Spring 2012 Regional Meeting Update.
Advertisements

Modify ABO Subtyping References for Consistency Operations and Safety Committee November 12-13, 2014.
Operations and Safety Committee Ms. Theresa Daly
Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation (Resolution 13) Ad Hoc.
Membership and Personnel Requirements for VCA Programs (Resolution 27) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid,
Proposal to Modify Existing or Establish New Requirements for the Psychosocial and Medical of Living Donors (Resolution 17) Living Donor Committee Mary.
Living Donor Committee Update Christie Thomas, MB, FRCP, FASN, FAHA Medical Director, Kidney Transplant Program University of Iowa Hospitals Chair, OPTN/UNOS.
Todd Franzen, MPA Community Relations Team Leader.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Living Donor Committee Update Mary Amanda Dew, PhD November 12-13, 2014.
Proposal to Require the Collection of Serum Lipase for all Pancreas Donors (Resolution 5) Pancreas Transplantation Committee Jonathan Fridell, MD, Chair.
Proposal to Clarify Data Submission Reporting and Documentation Requirements (Resolution 22) Membership & Professional Standards Committee (MPSC) Jonathan.
Proposed Revisions to and Reorganization of Policy 6.0 (Transplantation of Non-Resident Aliens) Sponsors: Ad Hoc International Relations Committee and.
Proposal to Delay the HCC Exception Score Assignment (Resolution 9) Liver and Intestine Committee David Mulligan, Chair November 12 and 13, 2014.
Proposed Membership and Personnel Requirements for Intestine Transplant Programs Liver and Intestinal Organ Transplantation Committee Spring 2015.
Proposal to Require Reporting of Every Islet Infusion to the OPTN Contractor within 24 Hours of the Infusion Pancreas Transplantation Committee Fall 2012.
Proposal To Modify Existing or Establish New Requirements for the Psychosocial and Medical Evaluation of all Living Donors Living Donor Committee Spring.
OFFICE OF THE CITY CLERK MARCH 24, 2014 CITY COUNCIL MEETING RESCIND RESOLUTION NO AND ADOPT A RESOLUTION ESTABLISHING THE RULES GOVERNING THE PASADENA.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Spring 2015.
OPTN Strategic Plan Maureen McBride United Network for Organ Sharing August 28, 2012.
Pediatric Training and Experience Requirements in the Bylaws OPTN/UNOS Board of Directors Eileen Brewer, MD, Chair William Mahle, MD, Vice Chair November.
OPTN OPTN/UNOS Ethics Committee Spring 2012 Regional Meeting Update Chair, Alexandra Glazier, MPH, JD Vice-Chair, Peter Reese, MD.
Proposal to Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation Ad Hoc Disease.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
Proposal to Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation Ad Hoc Disease.
Liver and Intestinal Organ Transplantation Committee Update David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Membership & Professional Standards Committee (MPSC)
Guidance for VCA Deceased Donor Authorization (Resolution 7)
Pediatric Transplantation Committee
Pediatric Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Pediatric Transplantation Committee
OFFICE OF THE CITY CLERK SEPTEMBER 22, 2014 CITY COUNCIL MEETING RESCIND RESOLUTION NO AND ADOPT A RESOLUTION ESTABLISHING THE RULES GOVERNING.
Membership and Professional Standards Committee
Pediatric Transplantation Committee
Mark S. Orloff, MD Regional Councillor
Proposal to Require the Reporting of Aborted Living Donor Organ Recovery Procedures (Resolution 19) Living Donor Committee Mary Amanda Dew, PhD.
Christie Thomas, MD, FRCP, FASN, FAHA Regional Councillor
OPTN/UNOS Thoracic Organ Transplantation Committee Dr. Joe Rogers
Pancreas Program Functional Inactivity
Action Items from the Kidney Transplantation Committee
Membership and Professional Standards Committee
Pediatric Transplantation Committee
Living Donor Committee
Living Donor Committee Spring 2014
Vascularized Composite Allograft (VCA) Transplantation Committee
Membership & Professional Standards Committee (MPSC)
Pediatric Transplantation Committee
Guidance on Effective Practices in Broader Distribution
David Reich, M.D., FACS Regional Councillor
Liver and Intestinal Organ Transplantation Committee Spring 2014
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Living Donor Committee Spring 2014
OPTN/UNOS Living Donor Committee
Informed Consent for Kidney Paired Donation
Liver and Intestinal Organ Transplantation Committee Spring 2014
Vascularized Composite Allograft Transplantation Committee Fall 2014
Living Donor Committee
Living Donor Committee
Living Donor Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Imminent and Eligible Death Data Definitions Change Effective Date
Elizabeth A. Pomfret, MD, PhD Regional Councillor
Vascularized Composite Allograft (VCA) Transplantation Committee
Pediatric Transplantation Committee
Living Donor Committee
Membership & Professional Standards Committee (MPSC)
Vascularized Composite Allograft (VCA) Transplantation Committee
VCA Committee Update Spring 2015.
Presentation transcript:

Proposal to Modify Existing or Establish New Requirements for the Informed Consent of Living Donors (Resolution 18) Living Donor Committee Mary Amanda Dew, PhD

 OPTN policy has inconsistent requirements for living donor informed consent  Kidney donor recovery hospitals must follow OPTN policies  Liver donor recovery hospitals must develop and follow center-specific protocols  Hospitals performing living lung, pancreas or intestine donor recovery are not required to follow OPTN policy or develop and follow center-specific protocols The Problem

#5- Promote Living Donor Safety Ensure that all living organ donors consent freely Maintain effective standards for the consent of living donors Strategic Plan

 Establish informed consent requirements for living liver, lung, pancreas, and intestine donors that mirror existing requirements for informed consent of living kidney donors  Improve informed consent process for future living liver, lung, pancreas and intestine donors Goal of the Proposal

 Extend standardization of the informed consent process to living donor liver, lung, pancreas and intestine programs How the Proposal will Achieve its Goal

Proposed requirements are based on recommendations from a Joint Societies Steering Committee and early comment from 5 OPTN Committees Joint Societies representation from: American Society of Transplantation (AST); American Society of Transplant Surgeons (ASTS); North American Transplant Coordinators Organization (NATCO) Background

Product Policy Target Population Impact: Living Donors Total IT Implementation Hours 0/10,680 Total Overall Implementation Hours 20/17,885 Overall Project Impact

TypeTotalSupportSupport as Amended OpposedNo vote/ No comment/ Did not consider Committee Regional119 (81.8%) 2 (18.2%) 00 Individual3123 (74.2%) 02 (6.4%) 6 (19.4%) Public Comment Results (3/13/14 – 6/13/14)

 June 2014 – Board approved VCA policies  Early September – Living Donor Committee leadership asked to extend proposed policy to include living VCA donors  September 8, 2014 – Committee heard presentation from VCA Committee Chair. Committee discussed and did not support extending proposed policy to VCA donors Post Public Comment Considerations

Reasons for Committee decision: SUMMARY 1.VCA not considered in policy development/public comment 2.Elements of policy are inaccurate/false for living VCA donors 3.Different types of living donor VCA will require different consent elements, none of which have received deliberation 4.It took years to implement consent policies for kidney donors despite large donation volume; no clear emergent problem for VCA requiring action without deliberation 5.Delaying passage of policy for liver, lung, pancreas and intestine donors in order to deliberate about VCA donors will not promote safety of these non-VCA donors

RESOLVED, that the following new or modified Policies 14.2.A (ILDA Requirements for Kidney Recovery Hospitals), 14.2.B (Protocols for Kidney Recovery Hospitals), 14.3 (Informed Consent Requirements), as set forth below are effective February 1, *Page 61 of Board book Resolution 18

Proposed requirements are based on recommendations from a Joint Societies Steering Committee and early comment from 5 OPTN Committees Joint Societies representation from: American Society of Transplantation (AST); American Society of Transplant Surgeons (ASTS); North American Transplant Coordinators Organization (NATCO) Additional Background

 Living donor recovery programs would be required to provide an ILDA and develop center specific ILDA protocols  Majority of existing (living kidney donor) informed consent requirements are extended to living liver, lung, pancreas, and intestine donors  Remaining informed consent requirements specific to living kidney donors are retained Proposal Summary

Includes new informed consent disclosure requirements specific to risks of living liver donation:  Acute liver failure  Transient liver dysfunction  Biliary complications  Need for blood products  Liver donation-related surgical complications  Abnormal post-donation lab results which could lead to additional testing with associated risks Proposal Summary

 Regions 3 and 11 (joint meeting) did not support the proposal because it would not require living donor programs to disclose the number of living donor deaths that had occurred at their program.  Committee response:  Policy is based on JSWG recommendations: center- specific risk data, including risk of death, should not be required within policy because most centers’ volume is too small to yield reliable estimates of risk of specific events, particularly when events are rare (as is the case with donor deaths) Public Comment Results

 ASTS supported the proposal as written  NATCO supported the proposal as written  AST supported the proposal and submitted comments about requirements for kidney donor consent which the Committee considered when preparing final proposed policy language Public Comment Results

Two organizations responded with concerns:  National Catholic Bioethics Center  National Catholic Partnership on Disability The Committee leadership prepared a detailed written response to address their concerns, met with group their representatives by conference call, received an additional letter from the groups, and sent written follow-up response. Public Comment Results: Individual

Primary concerns of Catholic organizations included:  Use of term “all,” as short-hand reference to kidney, liver, lung, pancreas, intestine donation, opens the door to donation of all tissues, not just those listed, and no matter how great the potential for donor harm, mutilation, and permanent disfigurement  Incomplete monitoring plan for living donor recovery hospitals Public Comment Results: Individual

 June 2014 – The Board approved VCA policies which allow for living VCA donation  Early September – Living Donor Committee leadership was asked to consider extending this informed consent policy to include living VCA donors  September 8, 2014 – VCA Committee Chair and Vice Chair presented the VCA policies and proposals during a full Living Donor Committee meeting, and responded to questions Post Public Comment Considerations

Timeline 3/13/14 – 6/13/14 Public comment 9/8/14 Committee hears presentation from VCA Committee Chair and finalizes proposal Late 8/14 Committee receives clarification that VCA policies include living donors 1/14 Committee completes work on proposal (inception 8/12) Late 6/14 Board approves VCA policies Early 9/14 Committee Leadership is asked to extend proposal to include VCA donors

 Request by the VCA Committee Chair to Living Donor Committee to extend this informed consent policy proposal to include living VCA donors to prevent “unregulated vacuum and to protect public safety and preserve the public trust.”  The Committee did not support extending this proposal to include living VCA donation for multiple reasons. Post Public Comment Considerations

 Reasons for lack of Committee support for including living VCA donation:  The Committee had specifically referred only to kidney, liver, pancreas, intestine, and lung donors in policy drafts and background supporting information  Informed consent requirements for living VCA donors were not considered a) by the JSWG during development of their policy recommendations, b) by the Committee during policy development, or c) during public comment Post Public Comment Considerations

 Reasons for lack of Committee support for including living VCA donation:  The policy contains elements that would be inaccurate or false when applied to living VCA donors.  Consider, for example, hand or limb donation. The following elements of policy would be false:  Informing donor of a “potential” change to the donor’s lifestyle from donation  Informing donor of a “potential” negative impact on ability to obtain/maintain disability insurance Post Public Comment Considerations

 Reasons for lack of Committee support for including living VCA donation:  The policy does not contain elements essential for full informed consent of living VCA donors.  Different categories of living VCA donation will require separate informed consent considerations, namely 1) limb and face, 2) multi- visceral as a composite (e.g., uterus+ovaries), and 3) other non-visceral organs.. Post Public Comment Considerations

 Reasons for lack of Committee support for including living VCA donation:  VCA transplantation is a life-enhancing, not life-saving procedure that could create a permanent disability in the living donor. This changes the ratio of donor risks relative to potential recipient benefits. The proposed policy is not adequate to address this ratio or to address the implications of permanent donor disability  It has taken years to develop, gain approval and implement informed consent policies for living kidney donation, which has the longest history and greatest volume. Absence of informed consent policies should not be considered an emergent problem. Post Public Comment Considerations

 Reasons for lack of Committee support for including living VCA donation:  Developing informed consent policy for living VCA donation needs careful consideration due to unique issues.  In the meantime, there is no clear rationale for delaying the policy approval process for informed consent policies for liver, lung, pancreas and intestine donors. Post Public Comment Considerations

 Reasons for lack of Committee support for including living VCA donation: SUMMARY  No consideration of VCA during policy development/public comment  Elements of policy are inaccurate and/or false for living VCA donors  Different types of living donor VCA will require different informed consent elements, none of which have received any deliberation Post Public Comment Considerations

 Reasons for lack of Committee support for including living VCA donation: SUMMARY  It took years to implement informed consent policies for living kidney donors despite large volume of donations; no clear emergent problem for VCA requiring action without deliberation  Delaying passage of policy to cover liver, lung, pancreas and intestine donors in order to deliberate about VCA donors will not promote safety of these non-VCA donors Post Public Comment Considerations

RESOLVED, that the following new or modified Policies 14.2.A (ILDA Requirements for Kidney Recovery Hospitals), 14.2.B (Protocols for Kidney Recovery Hospitals), 14.3 (Informed Consent Requirements), excluding lines 13, 109 and 110, as set forth below are effective February 1, *Page 61 of Board book Resolution 18